InMed Pharmaceuticals Inc (NASDAQ:INM) currently has a daily average trading volume of 6.72M but it saw 17294990 shares traded in last market. With a market cap of 1.40M USD, the company’s current market price of $0.42 came falling about -2.60 while comparing to the previous closing price of $0.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.08 and as low as $0.12. In the recent trading on the day, stock has struck highest price mark of $0.3751 while lowest mark touched by it was $0.45.
Taking a look at 20-day trading activity of InMed Pharmaceuticals Inc (INM) gives us an average price of $0.1990, while its current price level is -79.81% below from 52-week high level whereas it is 247.97% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2337 while that of 200 days or SMA-200 reads an average of $0.3207. A closer look into the stock’s movement over the week reveals that its volatility is standing at 32.04% during that period while stretching the period over a month that decreases to 17.94%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 76.47 which implies that the stock is in overbought territory.
Over the week, INM’s stock price is moving 183.21% up while it is 62.79% when we observe its performance for the past one month. Year-to-date it is 0.96% up and over the past year, the stock is showing a downside performance of -51.16%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -6.25 beat the consensus estimate of -6.25 for the same. The company is expected to be releasing its next quarterly report in September, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. Moreover, analysts are in estimates of $1.79M for current-quarter revenue.
Currently, InMed Pharmaceuticals Inc’s total number of outstanding shares is 3.33M with 0.58% of that held by the insiders while 3.11% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -51.36% and return on equity (ROE) at -51.73%. Stock’s beta reads 0.68. Stock has a price to book (P/B) ratio of 0.24 while price to sale or P/S ratio amounts to 0.25. Its return on asset (ROA) is -43.26% on average.
